Insulin says NO to cardiovascular disease

Cardiovascular Research
Qiujun YuXin L Ma


It is well recognized that insulin resistance found in patients with type 2 diabetes and obesity is a major risk factor for cardiovascular disease. Since its discovery in the 1920s, insulin has been used as an essential therapeutic agent in diabetes for blood glucose management. Recent studies demonstrate that insulin signalling is essential for normal cardiovascular function, and lack of it (i.e. insulin resistance) will result in cardiovascular dysfunction and disease. Moreover, insulin is the key component of glucose-insulin-potassium cocktail and exerts significant cardiovascular protective effect via a phosphatidylinositol 3'-kinase-protein kinase B-endothelial nitric oxide synthase (PI3K-Akt-eNOS)-dependent signalling mechanism in addition to its metabolic modulation, which renders it a potent organ protector in multiple clinical applications. This review focuses on insulin-initiated PI3K-Akt-eNOS survival signalling, with nitric oxide as an 'end effector' delivering cardioprotection in health and disease (especially in ischaemic heart disease), and highlights the impairment of this survival signalling as a key link between insulin resistance and cardiovascular disease.


Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y Xia, J L Zweier
Oct 23, 1997·The Journal of Clinical Investigation·H E BotkerT T Nielsen
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·E ClementiS Moncada
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·E ClementiS Moncada
Feb 19, 1999·Circulation Research·Y M KimT R Billiar
Aug 24, 1999·Cell·G L Semenza
Feb 9, 2000·American Journal of Physiology. Heart and Circulatory Physiology·P ZhuG G Schwartz
Feb 26, 2000·Cardiovascular Research·I Fleming, R Busse
Jun 10, 2000·The Journal of Biological Chemistry·L RössigS Dimmeler
Jul 25, 2000·Circulation Research·G HeuschR Schulz
Jan 3, 2001·Journal of Molecular and Cellular Cardiology·P S BrookesP G Anderson
May 11, 2001·Journal of Cardiovascular Pharmacology·A J CoatsS Anker
May 30, 2001·Nutrition·U N Das
Mar 5, 2002·American Journal of Respiratory and Critical Care Medicine·Naresh M PunjabiPhilip L Smith
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Gembu ImamuraDipak K Das
Jun 28, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicole S WaymanChristoph Thiemermann
Feb 8, 2003·Science·Enzo NisoliMichele O Carruba
Feb 25, 2003·British Journal of Pharmacology·Péter Ferdinandy, Richard Schulz
Sep 13, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Steven P JonesDavid J Lefer
Sep 26, 2003·Current Opinion in Critical Care·Undurti N Das
Jan 28, 2004·Circulation·W E FeemanChris Isles
Feb 14, 2004·Cardiovascular Research·Rainer SchulzGerd Heusch
Mar 11, 2005·European Heart Journal·G Van den Berghe

❮ Previous
Next ❯


Dec 23, 2011·Basic Research in Cardiology·Hanrui ZhangCuihua Zhang
Dec 25, 2010·Cardiovascular Research·Christopher G Kevil, David J Lefer
Oct 7, 2011·Clinical and Experimental Pharmacology & Physiology·Jerzy Bełtowski
May 12, 2012·Endocrine Reviews·Sabrina PrudenteVincenzo Trischitta
Feb 14, 2014·Diabetology & Metabolic Syndrome·Bruno Schmidt DellameaLuis Henrique Canani
Feb 21, 2013·Current Atherosclerosis Reports·Saloua El MessaoudiNiels P Riksen
Aug 28, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Hong YaoXiuzhen Han
Jul 19, 2012·Molecular and Cellular Biochemistry·Tao ChenZuyi Yuan
Jun 20, 2015·Nutrients·Jun KobayashiHiroyuki Uchida
Jun 6, 2014·Expert Opinion on Drug Safety·Lisa M YounkStephen N Davis
May 9, 2015·Journal of Molecular and Cellular Cardiology·Marcos PoncelasDavid Garcia-Dorado
Dec 27, 2011·Nitric Oxide : Biology and Chemistry·Manjulata SinghNiroj Kumar Sethy
Feb 3, 2015·Journal of Molecular and Cellular Cardiology·Simona GrecoFabio Martelli
Sep 1, 2015·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A K G VieiraA S Moura
Aug 30, 2011·Trends in Endocrinology and Metabolism : TEM·Shuai ChenCarol MacKintosh
Sep 15, 2012·Current Biology : CB·Teresa Niccoli, Linda Partridge
Jun 1, 2014·Free Radical Biology & Medicine·Brian E Sansbury, Bradford G Hill
Jul 2, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Qiurong Wang, Jun Ren
Dec 31, 2016·Biomolecules & Therapeutics·Supachoke MangmoolHitoshi Kurose
May 5, 2017·Cardiovascular Research·Gemma VilahurLina Badimon
Jul 9, 2016·Journal of Cardiovascular Pharmacology and Therapeutics·Grete SlettomJan E Nordrehaug

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Journal of Molecular and Cellular Cardiology
Maengjo Kim, Rong Tian
Experimental Gerontology
Mayuko NishimuraJérôme Cartry
European Journal of Heart Failure
Antoine H Chaanine, Roger J Hajjar
© 2021 Meta ULC. All rights reserved